Cold Patent

By Jeff Kemmer

After her son dies waiting for a gene therapy his insurer denied, a hospital billing analyst discovers the cure was never scarce at all-it was buried inside a biotech conspiracy designed to make the world beg for permanent, privatized immunity.

Mara Velez used to believe every denial had a chain of reasons behind it. A code. A form. A person who made the call.

Then her sixteen-year-old son died waiting for a treatment everyone said was in short supply.

Six weeks later, while closing out old hospital accounts no one expects her to question, Mara finds a shipment record that should not exist: thousands of doses of the same "unavailable" therapy stored off-books beneath the city's flagship pediatric hospital. Hidden. Guarded. Paid for.

When she pulls one thread, the whole fabric tears.

The shortage that killed her son was not a failure. It was a test. A biotech giant called HelixArc has been engineering panic to force governments into a new era of health security-one where immunity belongs to whoever can buy access, and disease becomes the most profitable leash in human history.

Now Mara is running with evidence men kill for. Chasing her is Adrian Vale, HelixArc's cold, brilliant operations chief-the man who built the system she wants to burn down. But as the bodies rise and a second, deadlier release moves into play, Mara faces the truth she hates most:

The monster hunting her may be the only one trying to stop what comes next.

• Format: Paperback
• Language: English
• ISBN: B0GY4S7GDX
• ISBN13: 9798258354600
• Release Date: April 2026
• Publisher: Independently Published
• Length: 352 Pages
• Weight: 1.04 lbs.
• Dimensions: 0.7" x 6.0" x 9.0"